Title: Vagus Nerve Stimulator Market 2021 Size, Growth Analysis Report, Forecast
1 Narcolepsy Treatment Market 2021 Product Type,
Sales, Supply, Demand, SWOT Analysis and Forecast
To 2028 FMI
Report Id REP-GB-7641Published On
2018-11-16Category Healthcare,
Pharmaceuticals Medical Devices
2AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
- Customized Research
- Syndicated Research
- Investment Research
- Social Media Research
- Automotive and Transportation
- Electronics, Semiconductor, and ICT
- Retail and Consumer Products
- Industrial Automation and Equipment
- Chemicals Materials
- Food and Beverages
- Services and Utilities
- Energy, Mining, Oil, and Gas
Subscription Information
For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
m
3Research Methodology (1/2)
- Systematic Research Approach
In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
FMI formulates a detailed discussion guide to conduct expert and industry interviews
FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts
FMI conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
FMI delivers industry insights and information in the required format (PDF)
- Identifying key opinion leaders
- Questionnaire design
- In-depth interviews
- Coverage across value chain
- Key industry experts
- Channel study
- Developments
- Market dynamics
- Products
- Conclusions
SOLUTION
- Market participants
- Key strengths
- Product portfolio
- Mapping as per value chain
- Key focus segments
Primary Research
Secondary Research
Paid Publications
- Linkedin
- Zoominfo
- Salesforce
- Avention
- Factiva
- GBI
- Genios
- Meltwater
- Company websites
- Company annual reports
- White papers
- Financial reports
includes sources of databases
4Narcolepsy Treatment Market Analysis
The worldwide market for narcolepsy treatment is
anticipated to account for a revenue estimation
of US 3,818 Million, recording a CAGR of 5.7,
during the forecast period 2018-2028. Future
Market Insights (FMI), in its recently published
market intelligence stance, spotlights
significant requirement for narcolepsy treatment
in North America. Narcolepsy treatment scenario
in Europe, would foresee remarkable revenue
expansion given the increasing affinity toward
the implementation of prescription treatments and
adherence to the similar on a long haul basis.
Narcolepsy is a rare condition, which is often
under diagnosed. The condition is characterized
by excessive sleepiness, hallucination, sleep
paralysis, excessive day time sleepiness,
cataplexy, and automatic behaviors. Narcolepsy is
caused due to lack of brain chemical known as
orexin which regulates sleep. Several other
factors can trigger narcolepsy such as menopause
and puberty. The condition is rare and is
estimated to affect more than 1 in 2000 people in
the U.S. The condition does not have any cure,
but drugs can improve the symptoms and bring
about changes in lifestyle.
5Narcolepsy Treatment Market Analysis
- Key Takeaways from Narcolepsy Treatment Market
Study - Foremost narcolepsy treatment makers are
prioritizing area-specific product expansion. The
product portfolio growth is majorly targeted in
the APAC region. - Apart from novel product expansion--majorly
increasing from the existence of low price
generic interpretations of patented drugs,
strategic acquisitions, and partnerships with
pave way for additional business growths. - Makers in the worldwide narcolepsy treatment
market are additionally concentrated towards
presenting novel RD units in several geographic
regions. - Industry leaders are centering on keeping up
long-term partnerships with pharmacies- in retail
and hospital, e-commerce, and drug stores. Sales
via e-commerce distribution channels are likely
to add a remarkable revenue share in the
worldwide narcolepsy treatment market. - FMI has additionally noted a rising center on the
preparation of well-known combinations and
products, by makers in North America to
accomplish wide penetration and higher sales.
6Narcolepsy Treatment Market Analysis
Request a Sample Report with Table of Contents
and Figures https//www.futuremarketinsights.com/
reports/sample/rep-gb-7641 There is a cognizant
transfer from OTC medication to devices handling
narcolepsy, fueling remarkable revenue expansion
for the devices category in contrast to drugs.
Increasing cases of inappropriate addiction and
medication, transforming into severe side effects
incorporate prolonged drowsiness, headache,
performance problems, and daytime memory, death
in some cases, and allergic reactions, is the
foremost increasing aspect. These side effects
are together with prescription-based in addition
to OTC sleep aids. Increasing the need to treat
narcolepsy with BiPAP is likely to boost this
fragment of devices--anticipated to increase at
the maximum CAGR. Additionally, devices in
portable in addition to available-for-rent
formats would translate into high implementation
rates, all over the assessment period. Portable
CPAP (Continuous Positive Airway Pressure)
devices are smaller and lighter and could also be
utilized as a home-based unit, moreover bringing
down the reliance on prescription drugs and OTC
pills.
7Narcolepsy Treatment Market Analysis
Whilst explaining the expansion trajectory of the
market, a senior analyst from the healthcare
field emphasizes increasing healthcare spending
and growing incidence events of orthopedic
disorders and fracture fixation as the foremost
aspects adding to the need for narcolepsy
treatment towards 2028 end. "Regulatory
inflictions by several worldwide authorities
incorporate the European Commission and FDA along
with altering taxation policies, regulations and
currency fluctuations are a few high-impact
aspects boosting the worldwide need for
narcolepsy treatment. Buy Now _at_
https//www.futuremarketinsights.com/checkout/7641
8Narcolepsy Treatment Market Analysis
Though the narcolepsy market is growing at a
remarkable CAGR, long awaiting time for sleep
services, and absence of awareness and held up
diagnosis, stern side effects of sleep aids
medication, absence of proper documentation for
the licensing and usage of sleeping pills, in
addition to unconventional equipment regulations
are a few critical aspects anticipated to
constrain the market development of narcolepsy
treatment. Competitive Landscape The
competition section of the narcolepsy treatment
market features profiles of key players operating
in the industry based on their market share,
product offerings for narcolepsy treatment,
differential strategies, company dashboard and
marketing approach. Some of the key players
featured in this report include Merck Co. Inc.,
Pfizer Inc., ResMed Inc., GlaxoSmithKline Plc.,
Fisher Paykel Healthcare Limited, Drive
DeVilbiss Healthcare LLC, Teva Pharmaceutical
Industries Ltd. (Cephalon, Inc.), Jazz
Pharmaceuticals plc, Mylan N.V., and
others. Download Market Shares of Leading
Players _at_ https//www.futuremarketinsights.com/ask
-question/rep-gb-7641
9To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)